155 related articles for article (PubMed ID: 30872423)
1. Determinants of Radiation Dose in Selective Ophthalmic Artery Chemosurgery for Retinoblastoma.
Qureshi AM; Davies LK; Patel PA; Rennie A; Robertson F
AJNR Am J Neuroradiol; 2019 Apr; 40(4):713-717. PubMed ID: 30872423
[TBL] [Abstract][Full Text] [Related]
2. Selective ophthalmic artery chemosurgery (SOAC) for retinoblastoma: fluoroscopic time and radiation dose parameters. A baseline study.
Boddu SR; Abramson DH; Marr BP; Francis JH; Gobin YP
J Neurointerv Surg; 2017 Nov; 9(11):1107-1112. PubMed ID: 29030462
[TBL] [Abstract][Full Text] [Related]
3. Technical and anatomical factors affecting intra-arterial chemotherapy fluoroscopy time and radiation dose for intraocular retinoblastoma.
Area C; Yen CJ; Chevez-Barrios P; Herzog C; Kan P; Zheng W; Lin F; Chintagumpala M; Gombos D; Chen SR
J Neurointerv Surg; 2019 Dec; 11(12):1273-1276. PubMed ID: 31197028
[TBL] [Abstract][Full Text] [Related]
4. Radiation dose reduction during intra-arterial chemotherapy for retinoblastoma: a retrospective analysis of 96 consecutive pediatric interventions using five distinct protocols.
Monroe EJ; Chick JFB; Stacey AW; Millard NE; Geyer JR; Ramoso LR; Ghodke BV; Hallam DK
Pediatr Radiol; 2021 Apr; 51(4):649-657. PubMed ID: 33231717
[TBL] [Abstract][Full Text] [Related]
5. Ophthalmic artery chemosurgery for less advanced intraocular retinoblastoma: five year review.
Abramson DH; Marr BP; Brodie SE; Dunkel I; Palioura S; Gobin YP
PLoS One; 2012; 7(4):e34120. PubMed ID: 22545080
[TBL] [Abstract][Full Text] [Related]
6. Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors.
Peterson EC; Elhammady MS; Quintero-Wolfe S; Murray TG; Aziz-Sultan MA
J Neurosurg; 2011 Jun; 114(6):1603-8. PubMed ID: 21294621
[TBL] [Abstract][Full Text] [Related]
7. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).
Abramson DH; Dunkel IJ; Brodie SE; Marr B; Gobin YP
Ophthalmology; 2010 Aug; 117(8):1623-9. PubMed ID: 20381868
[TBL] [Abstract][Full Text] [Related]
8. Ophthalmic artery chemosurgery for the management of retinoblastoma in eyes with extensive (>50%) retinal detachment.
Palioura S; Gobin YP; Brodie SE; Marr BP; Dunkel IJ; Abramson DH
Pediatr Blood Cancer; 2012 Nov; 59(5):859-64. PubMed ID: 22492689
[TBL] [Abstract][Full Text] [Related]
9. Intra-arterial chemotherapy in retinoblastoma - A paradigm change.
Manjandavida FP; Stathopoulos C; Zhang J; Honavar SG; Shields CL
Indian J Ophthalmol; 2019 Jun; 67(6):740-754. PubMed ID: 31124482
[TBL] [Abstract][Full Text] [Related]
10. Super selective ophthalmic artery delivery of chemotherapy for intraocular retinoblastoma: 'chemosurgery' the first Stallard lecture.
Abramson DH
Br J Ophthalmol; 2010 Apr; 94(4):396-9. PubMed ID: 20424209
[No Abstract] [Full Text] [Related]
11. Simultaneous Bilateral Ophthalmic Artery Chemosurgery for Bilateral Retinoblastoma (Tandem Therapy).
Abramson DH; Marr BP; Francis JH; Dunkel IJ; Fabius AW; Brodie SE; Mondesire-Crump I; Gobin YP
PLoS One; 2016; 11(6):e0156806. PubMed ID: 27258771
[TBL] [Abstract][Full Text] [Related]
12. Ophthalmic artery chemosurgery for eyes with advanced retinoblastoma.
Abramson DH; Fabius AW; Francis JH; Marr BP; Dunkel IJ; Brodie SE; Escuder A; Gobin YP
Ophthalmic Genet; 2017; 38(1):16-21. PubMed ID: 28095092
[TBL] [Abstract][Full Text] [Related]
13. Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience.
Gobin YP; Dunkel IJ; Marr BP; Brodie SE; Abramson DH
Arch Ophthalmol; 2011 Jun; 129(6):732-7. PubMed ID: 21320950
[TBL] [Abstract][Full Text] [Related]
14. Ten-year experience with ophthalmic artery chemosurgery: Ocular and recurrence-free survival.
Francis JH; Levin AM; Zabor EC; Gobin YP; Abramson DH
PLoS One; 2018; 13(5):e0197081. PubMed ID: 29791475
[TBL] [Abstract][Full Text] [Related]
15. Contralateral catheterization of the ophthalmic artery to deliver intra-arterial chemotherapy in retinoblastoma.
Saal-Zapata G; Rodríguez R; Rodriguez-Calienes A; Cordero R
Neuroradiol J; 2021 Aug; 34(4):370-372. PubMed ID: 34121503
[TBL] [Abstract][Full Text] [Related]
16. Chemosurgery for retinoblastoma: what we know after 5 years.
Abramson DH
Arch Ophthalmol; 2011 Nov; 129(11):1492-4. PubMed ID: 22084221
[No Abstract] [Full Text] [Related]
17. Efficacy and toxicity of second-course ophthalmic artery chemosurgery for retinoblastoma.
Francis JH; Abramson DH; Gobin YP; Marr BP; Tendler I; Brodie SE; Dunkel IJ
Ophthalmology; 2015 May; 122(5):1016-22. PubMed ID: 25616769
[TBL] [Abstract][Full Text] [Related]
18. Radiation dose reduction in intra-arterial chemotherapy infusion for intraocular retinoblastoma.
Cooke DL; Stout CE; Kim WT; Hetts SW; Higashida RT; Halbach VV; Dowd CF; Gould RG
J Neurointerv Surg; 2014 Dec; 6(10):785-9. PubMed ID: 24385553
[TBL] [Abstract][Full Text] [Related]
19. Intra-arterial chemotherapy for retinoblastoma: report No. 2, treatment complications.
Shields CL; Bianciotto CG; Jabbour P; Griffin GC; Ramasubramanian A; Rosenwasser R; Shields JA
Arch Ophthalmol; 2011 Nov; 129(11):1407-15. PubMed ID: 21670326
[TBL] [Abstract][Full Text] [Related]
20. Success of intra-arterial chemotherapy (chemosurgery) for retinoblastoma: effect of orbitovascular anatomy.
Marr BP; Hung C; Gobin YP; Dunkel IJ; Brodie SE; Abramson DH
Arch Ophthalmol; 2012 Feb; 130(2):180-5. PubMed ID: 22332209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
